Ji Won Woo

592 total citations
18 papers, 352 citations indexed

About

Ji Won Woo is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Ji Won Woo has authored 18 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Ji Won Woo's work include Cancer Immunotherapy and Biomarkers (7 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Ji Won Woo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Ji Won Woo collaborates with scholars based in South Korea, Puerto Rico and Ethiopia. Ji Won Woo's co-authors include So Yeon Park, Soomin Ahn, Kyoungyul Lee, Yul Ri Chung, Milim Kim, Hye Yeon Choi, Hyun Jeong Kim, Jee Hyun Kim, Se Hyun Kim and Min Hye Jang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Human Pathology.

In The Last Decade

Ji Won Woo

18 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Won Woo South Korea 10 219 118 89 82 58 18 352
Lauren Nye United States 9 270 1.2× 115 1.0× 34 0.4× 58 0.7× 76 1.3× 37 369
Carmine Valenza Italy 10 185 0.8× 87 0.7× 65 0.7× 76 0.9× 86 1.5× 47 311
Aiko Nagayama Japan 9 274 1.3× 100 0.8× 97 1.1× 74 0.9× 92 1.6× 27 394
Gennaro Palmiotti Italy 9 163 0.7× 61 0.5× 55 0.6× 74 0.9× 105 1.8× 22 332
Olga Oikonomidou United Kingdom 9 149 0.7× 119 1.0× 30 0.3× 102 1.2× 66 1.1× 28 320
Long-Zi Liu China 8 109 0.5× 81 0.7× 108 1.2× 96 1.2× 74 1.3× 8 325
Cécile Blanc‐Fournier France 13 117 0.5× 96 0.8× 71 0.8× 139 1.7× 50 0.9× 26 330
Sofia Westbom-Fremer Sweden 7 187 0.9× 56 0.5× 39 0.4× 56 0.7× 99 1.7× 12 299
Valentina Magri Italy 11 207 0.9× 132 1.1× 56 0.6× 66 0.8× 63 1.1× 28 345
Maartje van Seijen Netherlands 8 176 0.8× 163 1.4× 54 0.6× 57 0.7× 64 1.1× 14 337

Countries citing papers authored by Ji Won Woo

Since Specialization
Citations

This map shows the geographic impact of Ji Won Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Won Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Won Woo more than expected).

Fields of papers citing papers by Ji Won Woo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Won Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Won Woo. The network helps show where Ji Won Woo may publish in the future.

Co-authorship network of co-authors of Ji Won Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Won Woo. A scholar is included among the top collaborators of Ji Won Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Won Woo. Ji Won Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Woo, Ji Won, Hyun Jung Kwon, Yul Ri Chung, et al.. (2024). Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status. Laboratory Investigation. 104(8). 102092–102092. 1 indexed citations
2.
Woo, Ji Won, et al.. (2024). Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer. Breast Cancer Research and Treatment. 207(2). 301–311. 4 indexed citations
3.
Woo, Ji Won, et al.. (2023). PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance. Cancer Research and Treatment. 56(2). 557–566. 2 indexed citations
4.
Suh, Koung Jin, Se Hyun Kim, Yu Jung Kim, et al.. (2022). Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data. Journal of Breast Cancer. 25(5). 366–366. 10 indexed citations
5.
Han, Song‐Hee, Milim Kim, Yul Ri Chung, et al.. (2022). Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer. Scientific Reports. 12(1). 20367–20367. 12 indexed citations
6.
Woo, Ji Won, Hye Yeon Choi, Milim Kim, Yul Ri Chung, & So Yeon Park. (2022). miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast. Breast Cancer. 29(5). 814–824. 3 indexed citations
7.
Ahn, Soomin, Ji Won Woo, Hyojin Kim, et al.. (2021). Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability. Journal of Breast Cancer. 24(3). 266–266. 14 indexed citations
8.
Kim, Milim, Hye Yeon Choi, Ji Won Woo, Yul Ri Chung, & So Yeon Park. (2021). Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast. Scientific Reports. 11(1). 18007–18007. 24 indexed citations
9.
Chung, Yul Ri, Ji Won Woo, Soomin Ahn, et al.. (2021). Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Scientific Reports. 11(1). 12128–12128. 3 indexed citations
10.
Kim, Milim, Yul Ri Chung, Hyun Jeong Kim, et al.. (2020). Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Research. 22(1). 32–32. 36 indexed citations
11.
Ahn, Soomin, Yul Ri Chung, An Na Seo, et al.. (2020). Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer. PLoS ONE. 15(5). e0233037–e0233037. 15 indexed citations
12.
Woo, Ji Won, Yul Ri Chung, Milim Kim, et al.. (2020). Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers. Cancer Immunology Immunotherapy. 70(5). 1365–1378. 6 indexed citations
13.
14.
Woo, Ji Won, Yul Ri Chung, Soomin Ahn, et al.. (2019). Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value. Journal of Breast Cancer. 22(3). 439–439. 21 indexed citations
15.
16.
Ahn, Soomin, Ji Won Woo, Kyoungyul Lee, & So Yeon Park. (2019). HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation. Journal of Pathology and Translational Medicine. 54(1). 34–44. 155 indexed citations
17.
Kim, Chi Heon, et al.. (2016). The usefulness of a mobile device-based system for patient-reported outcomes in a spine outpatient clinic. The Spine Journal. 16(7). 843–850. 16 indexed citations
18.
Woo, Ji Won, et al.. (2014). Improvement of dye-sensitized solar cell performance through infiltration of TiO2 nanoparticles between mesoporous TiO2 particles. Materials Research Bulletin. 58. 88–92. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lauren Nye Breakdown of academic impact, for papers by Carmine Valenza Breakdown of academic impact, for papers by Aiko Nagayama Breakdown of academic impact, for papers by Gennaro Palmiotti Breakdown of academic impact, for papers by Olga Oikonomidou Breakdown of academic impact, for papers by Long-Zi Liu Breakdown of academic impact, for papers by Cécile Blanc‐Fournier Breakdown of academic impact, for papers by Sofia Westbom-Fremer Breakdown of academic impact, for papers by Valentina Magri Breakdown of academic impact, for papers by Maartje van Seijen
Rankless by CCL
2026